Inclusion Criteria~1. Male or female subjects aged 55-80 years at the time of signing the Informed Consent
Form.~2. Subjects (or subject's legally acceptable representative) and caregiver(s) who can sign an Informed
Consent to participate in the study. Same caregiver(s) must assist the subject throughout the entire duration
of the study.~3. Subjects who have a diagnosis of probable Alzheimer's disease according to the NIA-AA
(National Institute of Aging and Alzheimer's Associations, 2011) criteria with mild to moderate dementia (stage
4 - 5) at screening.~4. Subjects who have mild-to-moderate cognitive impairment with MMSE Score of 16-26 at
screening.~5. Subjects who have an MRI (either 1.5T or 3T) or CT scan performed after onset of symptoms and
prior to randomization with findings consistent with the diagnosis of dementia due to Alzheimer's disease and
without any other clinically significant comorbid pathologies.~6. Subjects who have one (or more) identified
adult study partner(s) who, in the opinion of the investigator, has sufficient contact with and knowledge about
the subject as to be able to report knowledgeably about the subject's safety, compliance and adherence,
cognition, function, and behavior.~
